首页> 中文期刊>中国临床医学影像杂志 >肝血管瘤介入治疗中栓塞剂的选用及方法探讨(附15例报告)

肝血管瘤介入治疗中栓塞剂的选用及方法探讨(附15例报告)

     

摘要

Objective: To evaluate the efficacy of different embolic agents and methods of embolization of hepatic hemangioma (HHE). Methods: Fifteen cases of HHE were randomly devided into two groups. Five cases in group A were treated either with intra-tumor sclerotherapy embolization of the main arterial supply to HHE. There were ten cases in group B, who were treated by using both methods. Results: In 15 cases tumor contrast staining disappeared immediately after embolization, arterial blood supply was cut and all had symptoms relief or even completely recovered. The cases were followed-up for two months to one year, two cases in group A had tumor size increased and symptoms reoccurred. Ten cases in group B had different degree of decreasing in tumor size and no symptoms reoccurred. Conclusion: Combination of using sclerosing agent within the tumor and embolization of arterial blood-supply is more effective than simply use one method either intra-tumor sclerosing or only embolization of the arterial blood supply to the tumor. There is significant difference between the two methods (P<0. 05).%目的:研究和探讨不同的栓塞剂和栓塞方法治疗肝血管瘤的效果。方法:对15例肝血管瘤随机分两组,A组单纯瘤体内栓塞或仅供血动脉干栓塞,共5例,B组瘤体内硬化剂灌注加供血动脉干双重栓塞10例。结果:15例肝血管瘤病人栓塞后瘤体染色消失,供血动脉中断,症状减轻或消失。随访2个月~1年,A组中2例瘤体增大,症状复发;B组10例瘤体均有不同程度缩小,无复发。结论:肝血管瘤瘤体内硬化剂灌注加供血动脉阻断,其疗效优于单纯瘤体栓塞或仅做供血动脉干栓塞,两者有显著性差异(P<0.05)。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号